176 related articles for article (PubMed ID: 30503610)
1. Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma.
Yeon Yeon S; Jung SH; Jo YS; Choi EJ; Kim MS; Chung YJ; Lee SH
Pathol Res Pract; 2019 Jan; 215(1):209-214. PubMed ID: 30503610
[TBL] [Abstract][Full Text] [Related]
2. Majority of
Middha S; Yaeger R; Shia J; Stadler ZK; King S; Guercio S; Paroder V; Bates DDB; Rana S; Diaz LA; Saltz L; Segal N; Ladanyi M; Zehir A; Hechtman JF
JCO Precis Oncol; 2019; 3():. PubMed ID: 31008436
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer.
Snahnicanova Z; Kasubova I; Kalman M; Grendar M; Mikolajcik P; Gabonova E; Laca L; Caprnda M; Rodrigo L; Ciccocioppo R; Kruzliak P; Plank L; Lasabova Z
Clin Exp Med; 2020 Feb; 20(1):87-95. PubMed ID: 31853669
[TBL] [Abstract][Full Text] [Related]
5. B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy.
Zhang C; Li D; Xiao B; Zhou C; Jiang W; Tang J; Li Y; Zhang R; Han K; Hou Z; Zhang L; Sui Q; Liao L; Pan Z; Zhang X; Ding P
J Immunother; 2022 May; 45(4):187-193. PubMed ID: 35343934
[TBL] [Abstract][Full Text] [Related]
6. Mutational profiling of colorectal cancers with microsatellite instability.
Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
[TBL] [Abstract][Full Text] [Related]
7. Frameshift mutations in mammalian target of rapamycin pathway genes and their regional heterogeneity in sporadic colorectal cancers.
Choi MR; Yoo NJ; An CH; Lee SH
Hum Pathol; 2015 May; 46(5):753-60. PubMed ID: 25776026
[TBL] [Abstract][Full Text] [Related]
8. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
Barrow P; Richman SD; Wallace AJ; Handley K; Hutchins GGA; Kerr D; Magill L; Evans DG; Gray R; Quirke P; Hill J
Histopathology; 2019 Aug; 75(2):236-246. PubMed ID: 31062389
[TBL] [Abstract][Full Text] [Related]
9. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
[TBL] [Abstract][Full Text] [Related]
10. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
[TBL] [Abstract][Full Text] [Related]
11. High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.
Niittymäki I; Gylfe A; Laine L; Laakso M; Lehtonen HJ; Kondelin J; Tolvanen J; Nousiainen K; Pouwels J; Järvinen H; Nuorva K; Mecklin JP; Mäkinen M; Ristimäki A; Ørntoft TF; Hautaniemi S; Karhu A; Kallio MJ; Aaltonen LA
Carcinogenesis; 2011 Mar; 32(3):305-11. PubMed ID: 21163887
[TBL] [Abstract][Full Text] [Related]
12.
Busch E; Ahadova A; Kosmalla K; Bohaumilitzky L; Pfuderer PL; Ballhausen A; Witt J; Wittemann JN; Bläker H; Holinski-Feder E; Jäger D; von Knebel Doeberitz M; Haag GM; Kloor M
Front Oncol; 2021; 11():669774. PubMed ID: 34168989
[TBL] [Abstract][Full Text] [Related]
13. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability.
Choi EJ; Kim MS; Song SY; Yoo NJ; Lee SH
Pathol Oncol Res; 2017 Jan; 23(1):145-149. PubMed ID: 27620344
[TBL] [Abstract][Full Text] [Related]
16. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
[TBL] [Abstract][Full Text] [Related]
17. [The significance and characteristics of chromosomal abnormalities in patients with microsatellite and chromosome stable colorectal carcinoma].
Xie D; Wu HX; Liu YD; Zeng SD; Lin F
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):11-5. PubMed ID: 17403304
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
19. High numbers of PDCD1 (PD-1)-positive T cells and
Janikovits J; Müller M; Krzykalla J; Körner S; Echterdiek F; Lahrmann B; Grabe N; Schneider M; Benner A; Doeberitz MVK; Kloor M
Oncoimmunology; 2018; 7(2):e1390640. PubMed ID: 29308317
[TBL] [Abstract][Full Text] [Related]
20. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
